8-KShareholder Matters

BOSTON SCIENTIFIC CORP 8-K Report, Shareholder Vote Results (May 9, 2023)

Filed May 9, 2023For Securities:BSX

Summary

Boston Scientific Corporation (BSX) filed an 8-K report on May 8, 2023, detailing the outcomes of its 2023 Annual Meeting of Stockholders held on May 4, 2023. The meeting, conducted virtually, saw all nine director nominees re-elected for one-year terms, indicating strong shareholder confidence in the current board leadership. Key resolutions also passed with significant shareholder approval, including the advisory vote on executive compensation, often referred to as "say-on-pay," and the ratification of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year 2023. Furthermore, shareholders overwhelmingly favored an annual frequency for future advisory votes on executive compensation, reinforcing a preference for regular oversight of management pay.

Key Highlights

  • 1All nine director nominees were successfully elected to the Board of Directors, each for a one-year term.
  • 2Shareholders overwhelmingly approved the "say-on-pay" proposal, endorsing the compensation of Named Executive Officers.
  • 3A strong majority of shareholders voted for an annual frequency for future advisory votes on executive compensation.
  • 4The appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2023 was ratified by shareholders.
  • 5The virtual format of the Annual Meeting aimed to provide broad accessibility to shareholders.

Frequently Asked Questions

The key outcomes include the re-election of all nine director nominees, approval of executive compensation (say-on-pay) on an advisory basis, and the ratification of Ernst & Young LLP as the independent auditor. Shareholders also voted to hold future advisory votes on executive compensation annually.

All nine director nominees received a substantial majority of votes cast 'for' their election, indicating strong shareholder support for the current board.

The 'say-on-pay' vote is an advisory (non-binding) vote by shareholders on the compensation of the company's top executives. The overwhelming approval suggests shareholders are generally satisfied with the executive compensation structure and levels disclosed.

Boston Scientific will hold future advisory votes on executive compensation on an annual basis, as overwhelmingly favored by the shareholders at this meeting.